Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03074526 · ClinicalTrials.gov registry record · NA
Protocol for the Clinical Evaluation of Lyophilized Amniotic Fluid in the Treatment of Knee Osteoarthritis
A NA study, sponsored by MiMedx Group.
- Completed
- Registry status
- NA
- Development phase
- 156
- Enrollment target
NCT03074526 is a NA study that has completed, run by MiMedx Group. The registered enrollment target is 156 participants.
The verdict
NCT03074526, a NA study, has completed, sponsored by MiMedx Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 156 participants
- Enrollment target
Study Summary
To evaluate the efficacy of Lyophilized amniotic fluid as compared to the Saline Injection, placebo control in the treatment of moderate osteoarthritis of the knee.
Interventions
- OTHER Saline Placebo
- OTHER Amniotic Fluid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2017-01-23 |
| Est. Completion | 2018-04-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03074526
The ClinicalTrials.gov registry entry for NCT03074526 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MiMedx Group, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline Placebo is the first listed.
NCT03074526 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03074526 about?
NCT03074526 is a clinical study titled "Protocol for the Clinical Evaluation of Lyophilized Amniotic Fluid in the Treatment of Knee Osteoarthritis". To evaluate the efficacy of Lyophilized amniotic fluid as compared to the Saline Injection, placebo control in the treatment of moderate osteoarthritis of the knee.
What is the current status of trial NCT03074526?
This trial is currently completed. It is a NA study. The enrollment target is 156 participants. The study started on 2017-01-23. Estimated completion is 2018-04-25.
What interventions are being tested in trial NCT03074526?
The interventions under investigation include: Saline Placebo (OTHER), Amniotic Fluid (OTHER).
Who is sponsoring clinical trial NCT03074526?
This trial is sponsored by MiMedx Group, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.